Seattle’s Juno Therapeutics, at work on treatments that train the immune system to better fight cancer, has signed a deal to expand its pipeline of therapies, licensing a complementary candidate developed by the National Cancer Institute.

…read more

Source: Juno expands its CAR-T arsenal with latest immuno-oncology deal


0 No comments